enVVeno Medical Corp Gain (Loss) on Disposition of Assets
enVVeno Medical Corp (NVNO) reported Gain (Loss) on Disposition of Assets of -$27.80 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2022-03-28
- enVVeno Medical Corp gain (loss) on disposition of assets for fiscal 2020 was -$27.80K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2020-12-31 | -$27.80K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |